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A functional AT/G polymorphism in the 5′-untranslated
region of SETDB2 in the IgE locus on human
chromosome 13q14
RJ Holt1, C Vandiedonck1, SA Willis-Owen2, JC Knight1, WO Cookson2, MF Moffatt2,3 and Y Zhang2,3
The immunoglobulin E (IgE)-associated locus on human chromosome 13q14 inﬂuencing asthma-related traits contains the genes
PHF11 and SETDB2. SETDB2 is located in the same linkage disequilibrium region as PHF11 and polymorphisms within SETDB2 have
been shown to associate with total serum IgE levels. In this report, we sequenced the 15 exons of SETDB2 and identiﬁed a single
previously ungenotyped mutation (AT/G, rs386770867) in the 5′-untranslated region of the gene. The polymorphism was found to
be signiﬁcantly associated with serum IgE levels in our asthma cohort (P= 0.0012). Electrophoretic mobility shift assays revealed
that the transcription factor Ying Yang 1 binds to the AT allele, whereas SRY (Sex determining Region Y) binds to the G allele.
Allele-speciﬁc transcription analysis (allelotyping) was performed in 35 individuals heterozygous for rs386770867 from a panel of
200 British families ascertained through probands with severe stage 3 asthma. The AT allele was found to be signiﬁcantly
overexpressed in these individuals (P= 1.26 × 10− 21). A dual-luciferase assay with the pGL3 luciferase reporter gene showed that
the AT allele signiﬁcantly affects transcriptional activities. Our results indicate that the IgE-associated AT/G polymorphism
(rs386770867) regulates transcription of SETDB2.
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INTRODUCTION
Asthma is a complex disease underpinned by a combination of
genetic and environmental factors. Positional cloning and
genome-wide association studies have resulted in the identiﬁca-
tion of a number of loci that inﬂuence asthma and asthma-related
traits such as total serum immunoglobulin E (IgE).1 An under-
standing of the function of the genes within these loci as well as
their regulation will provide important insights into their roles in
disease.
Previously, we have reported a highly signiﬁcant genetic
association between a locus on human chromosome 13 and total
serum IgE.2 The locus contains the genes PHF11 and SETDB2.
Both genes are in the same linkage disequilibrium (LD) block and
are separated by a mere 4 kb. The association between single-
nucleotide polymorphisms in PHF11 and asthma, or asthma-
associated traits, has been investigated in many subsequent
studies, with reports conﬁrming the association in a number of
ethnic populations.3–5 It is notable, however, that two studies have
failed to replicate the original ﬁnding6,7 potentially due to true
differences in the effect of PHF11 variants between groups
(e.g. due to variation in environmental exposures or through
epistatic or gene–environment interactions) and variance in the
patterns of LD between typed and true causative variants.
SETDB2 is transcribed in the same direction as PHF11 and
cotranscripts extending from SETDB2 to PHF11 exist in many
human tissues.2 Owing to the small intervening distance and the
LD structure between these genes, it is not currently possible to
delineate the relative roles of SETDB2 and PHF11 in asthma and its
associated traits. SETDB2 has a methyl-CpG-binding domain and
SET domain that modulates gene expression epigenetically
through histone H3 lysine methylation. Abnormal histone
methylation has been found in many diseases including
asthma.8 In this report, we sequenced the 15 exons of SETDB2
to discover new polymorphisms that may underlie asthma-
associated traits. We identiﬁed an AT/G mutation (rs386770867),
comprising both an insertion and substitution at the same locus,
positioned in the 5′-untranslated region (UTR) of SETDB2. We
genotyped this variant in our family-based cohorts of asthma and
then investigated its role in the regulation of SETDB2 using
electrophoretic mobility shift assays (EMSAs), alleotyping and dual
reporter gene assay analysis.
RESULTS
SETDB2 sequencing and genotyping
Sequencing of the 15 exons of SETDB2 in 10 diploid genomes
(ﬁve unrelated individuals with atopic disease and ﬁve unrelated
control individuals) together with a pool of DNA from 32 unrelated
individuals resulted in the identiﬁcation of three mutations. Two
missense mutations located in exons 7 and 10 had been
genotyped in our previous work (referenced as d8ex7 and
d8ex10).2 The third variant was an AT/G mutation located in the
5′-UTR of exon 1 and subsequently was designated as rs386770867
in the NCBI dbSNP database (Figures 1a and b). Previously, we had
identiﬁed and genotyped 12 SNPs in the SETDB2 region in an
asthma cohort, ﬁnding association of IgE with three (rs7998427,
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P= 0.02; b1_2, P= 0.008; rs11619265, P= 0.002).2 We therefore
genotyped rs386770867 ﬁrst in the Australian panel of families,
and found that the mutant allele (AT) was signiﬁcantly associated
not only with total serum IgE levels (P= 0.0012) but also to the
phenotype of RASTI (Radio AllergoSorbent Testing Index; the
index of the sum of serum IgE levels to the two allergens of house
dust mite and grass pollen) (P= 0.002), both of which are asthma-
related phenotypes. The signiﬁcant association with RASTI was
also found in the UK panel (P= 0.01), making this SNP the most
strongly associated with asthma-related traits in SETDB2 (Table 1).
Transcription factor binding analysis of rs386770867
The sequence spanning rs386770867 was examined using the
transcription factor binding prediction programs TFSearch,9 TFScan10
and MatInspector.11 Three transcription factors (HS$IL6_06, HS
$GG_12 [NF-E] and SRY) were predicted to bind the region
independently of the mutation. One transcription factor, HS
$GMCSF_04 (Ying Yang 1 (YY1)), was predicted to bind the AT allele
only, whereas v-Myb was predicted to bind only the G allele (Table 2).
Transcription factor binding is modulated in vitro by rs386770867
Initial EMSAs using BEAS-2B (bronchial epithelial cell line), Calu-3
(airway epithelial cell line) and Daudi (male B lymphoblast) nuclear
extracts identiﬁed three major complexes (Figure 2a). Complex 1
was present for both alleles for all the nuclear extracts. Complex 3
formed for the AT allele alone, and again was present for all three
nuclear extracts. Complex 2, however, was only observed using
the G allele probe and the Daudi nuclear extract. To conﬁrm the
speciﬁcity of complexes 2 and 3, a series of competition assays
were performed using molar excesses of unlabelled probes for
each allele, and an unrelated sequence. Competition assays using
Calu-3 nuclear extract demonstrated that for both the AT and G
probes binding to complex 1 was efﬁciently competed using
unlabelled probes for either allele. The intensity of complex 3 was,
however, only reduced in the presence of the unlabelled AT probe
(Figure 2b). This was also seen for the Daudi nuclear extract
(Figure 2c). Complex 2 was only efﬁciently competed in the
presence of the unlabelled G probe (Figure 2c). The data
Figure 1. (a) The location of the AT/G mutation in the UTR of SETDB2. Position of the AT/G mutation is on chr13: 50 018 841–50 018 842 (Build
Hg19), it is located at − 492/− 493 before the translation codon ATG of SETDB2. (b) Sequence showing the rs386770867 polymorphism.
Table 1. Details of association between rs386770867 and the asthma-related traits of IgE level and RASTI
Polymorphism MAF (AT) Location Position (Build Hg19) AUS1 UK1
LnIgE RASTI LnIgE RASTI
AT/G 0.42 SETDB2 5′-UTR Chr13: 50 018 841–50 018 842 0.0012 0.0016 0.0963 0.01
Abbreviations: IgE, immunoglobulin E; LnIgE, loge of total serum IgE; MAF, minor allele frequency; UTR, untranslated region; RSATI, Radio Allergo-Sorbent
Testing Index; index of speciﬁc serum IgE titre against allergens house dust mite and grass pollen using radioallergosorbent test.
Table 2. Transcription factors predicted to bind the AT and G alleles of
rs386770867
Allele Program Transcription
factor
Strand Sequence
(5′–3′)
Score
AT TFSearch SRY − TGAGTTT 87.3
TFScan HS$IL_06 + TTCC —
HS$GMCSF_04 + CATTT —
HS$GG_12 + CTGTC —
+ CTGTC —
G− TFSearch SRY − TGAGTTT 87.3
TFScan HS$GG_12 + CTGTC —
+ CTGTC —
MatInspector v-Myb (Viral?) − CTGAACGGAGG 0.915
Searches were performed using the programs TFSearch,9 TFScan10 and
MatInspector.11 The polymorphism is shown in boldface in the transcrip-
tion factor binding sequences. The score is as reported by the search
program. No scores are reported by TFScan (indicated by a dash). For
MatInspector, the matrix similarity score is given; a value of 1 indicates a
perfect match. For TFSearch, a score of 100 indicates a perfect match.
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demonstrated the speciﬁc binding of proteins for both AT and G
alleles of rs386770867.
To identify the proteins responsible for the allele-speciﬁc
complexes, supershift assays were performed using antibodies
for the transcription factors implicated by the bioinformatic
analyses of the region: SRY, YY1 and c-Myb. In addition, a reaction
using an Oct-1 antibody, not implicated to bind either allele, was
included as a negative control. Complex 3 was supershifted in the
presence of anti-YY1, whereas complex 2 was abolished by
anti-SRY (Figure 2d). Complex 1 was unaffected by any of the
antibodies tested.
Allelotyping
To determine the effect of the allele-speciﬁc transcription factor
binding on SETDB2, the relative expression of the two alleles in
heterozygous individuals was investigated by allelotyping.12,13 The
35 heterozygotes for rs386770867 were identiﬁed by genotyping
the MRC-A/RNA cohort. For each of the heterozygous individuals,
eight replicate matrix-assisted laser desorption/ionization geno-
typing reactions were performed using both genomic DNA and
cDNA for each individual.
The AT:G ratio of peak areas for each replicate genomic DNA
result was calculated for all samples. Replicate results outside the
1.5x interquartile range were excluded as outliers (N= 9), and the
mean of the remaining data calculated (mean= 1.78; N= 295). The
AT:G peak area ratio in the cDNA of the 35 individuals was
compared with the mean ratio from the genomic DNA using a
paired-samples t-test. This revealed a modest, but highly
signiﬁcant preferential expression of the AT allele across the 35
individuals as a whole (cDNA mean= 2.07; gDNA mean= 1.78;
difference of means = 0.286; 95% conﬁdence interval (CI) of the
difference = 0.232–0.340; fold change = 1.16; P= 1.26 × 10− 21).
Limiting the analysis to include only those individuals with no
outlying replicate cDNA results (N= 29) conﬁrmed the original
ﬁnding (cDNA mean = 2.10; gDNA mean= 1.78; difference of
means = 0.314; 95% CI of the difference = 0.269–0.358; fold
change= 1.18; P= 5.66 × 10− 32) (Table 3). Comparison of each
patient separately to the genomic DNA ratio identiﬁed 25
individuals with preferential expression of the AT allele, and 1
for the G allele (Po0.05) (Table 3). Signiﬁcant differences were
also observed for both sexes when analysed separately, although
preferential expression of the AT allele appears to be stronger in
males (cDNA mean = 2.17; gDNA mean= 1.78; difference of
means = 0.381; 95% CI of the difference = 0.306–0.457; fold
change= 1.21; P= 5.07 × 10− 18) compared with that in females
(cDNA mean=1.96; gDNA mean=1.78; difference of means= 0.171;
Figure 2. (a) EMSA results for rs386770867 using BEAS-2B, Calu-3 and Daudi nuclear extracts A total of 5 μg of nuclear extract was used per
reaction. (b) Competition EMSA using Calu-3 nuclear extract. Excess of cold probe used was 10x, 50x and 100x with 5 μg of nuclear extract
used per reaction. (c) Competition EMSA using 5 μg of Daudi nuclear extract and 10x, 50x and 100x excesses of cold probe. (d) Supershift assay
using 5 μg of Daudi cell nuclear extract per reaction.
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95% CI of the difference = 0.100–0.242; fold change = 1.10;
P= 6.35 × 10− 6) (Table 3).
Dual-luciferase reporter assay results
Jurkat T cells were cultured for the dual-luciferase reporter assay.
The Renilla pRL-SV40 plasmid was used as a control for the
transfection efﬁciency. The luciferase expression was documented
as average relative light units/pGL3 control. The AT allele plasmid
showed signiﬁcantly greater expression levels of luciferase
compared with the pGL3 vector (Po0.01). The G-allele plasmid
showed slightly lower expression of luciferase compared with the
pGL3 vector, but this difference was not statistically signiﬁcant in
Jurkat T cells (Figure 3).
DISCUSSION
Chromosome 13q was ﬁrst shown to associate with asthma-
related traits by whole-genome linkage analysis in 1996.14
Subsequently, the genes PHF11 and SETDB2 were implicated by
positional cloning of the locus.2,15 Our earlier genetic analyses had
indicated that variation in total serum IgE levels was attributable,
at least in part, to variation in the PHF11 gene on chromosome
13q14. The coordinate regulation of PHF11 and the nearby gene
SETDB2 and the possible presence of more distant alleles
inﬂuencing association suggested, however, that investigation of
the function of the locus should include the two genes within
this locus.
SETDB2 is a histone H3 lysine 9 methyltransferase that
modulates gene expression epigenetically through histone H3
methylation.16 Methylation of histone H3 at lysine 9 has emerged
as an important player in the formation of heterochromatin,
chromatin condensation and transcriptional repression. Depletion
of SETDB2 coincides with a loss of CENP proteins and delayed
mitosis, suggesting that SETDB2 participates in chromosome
condensation and segregation.16 Knockdown of Setdb2 in zebra-
ﬁsh results in a massive expansion of dorsal organizer markers
ﬂoating head, goosecoid and chordin, as well as a signiﬁcant
Table 3. Paired-samples t-test results for individual rs386770867 heterozygous samples
Sample N n Mean
cDNA AT:G
Diff of means
(cDNA–gDNA)
95%
CI diff
Lower Upper Sig. Overexpressed
allele
Fold change
8016_4 8 7 2.7290 0.9447 0.2841 0.661 1.229 0.001 AT 1.5295
8036_3 8 8 2.2489 0.4645 0.1243 0.340 0.589 0.0002 AT 1.2603
8036_4 8 8 2.3455 0.5612 0.6067 − 0.046 1.168 0.1127 N/A 1.3145
8046_4 8 8 2.0783 0.2940 0.1860 0.108 0.480 0.0174 AT 1.1648
8052_4 8 7 2.2372 0.4528 0.0483 0.405 0.501 1.677E− 06 AT 1.2538
8060_5 8 8 2.0232 0.2389 0.0579 0.181 0.297 8.481E− 05 AT 1.1339
8062_4 8 8 1.9644 0.1801 0.1141 0.066 0.294 0.017 AT 1.1009
8067_3 8 8 1.5871 − 0.1973 0.1887 − 0.386 − 0.009 0.091 N/A 0.8895
8080_3 8 8 2.5434 0.7590 0.1593 0.600 0.918 3.347E− 05 AT 1.4254
8080_5 8 8 2.1789 0.3946 0.0975 0.297 0.492 9.641E− 05 AT 1.2212
8081_4 8 8 2.2138 0.4295 0.1887 0.241 0.618 0.003 AT 1.2407
8100_3 8 8 1.9241 0.1398 0.1342 0.006 0.274 0.080 N/A 1.0784
8103_4 8 6 0.6981 − 1.0862 0.0220 − 1.108 − 1.064 2.228E− 09 G 0.3912
8110_4 8 8 2.0563 0.2720 0.1438 0.128 0.416 0.0076 AT 1.1525
8111_5 8 7 2.1026 0.3183 0.0708 0.247 0.389 0.0001 AT 1.1784
8122_4 8 8 1.9307 0.1464 0.1292 0.017 0.276 0.0618 N/A 1.0820
8127_3 8 8 2.0927 0.3084 0.1382 0.170 0.447 0.0033 AT 1.1729
8135_3 8 8 1.9250 0.1407 0.2013 − 0.061 0.342 0.2131 N/A 1.0788
8135_4 8 7 1.7092 − 0.0751 0.1454 − 0.220 0.070 0.3502 N/A 0.9579
8136_3 8 8 2.2603 0.4760 0.1183 0.358 0.594 9.988E− 05 AT 1.2667
8146_3 8 8 1.8690 0.0847 0.1456 − 0.061 0.230 0.2916174 N/A 1.0475
8146_4 8 8 2.1852 0.4009 0.1167 0.284 0.518 0.0003 AT 1.2247
8148_4 8 8 1.9540 0.1697 0.1202 0.050 0.290 0.0278 AT 1.0951
8148_5 8 8 1.9686 0.1843 0.0895 0.095 0.274 0.0049 AT 1.1033
8154_3 8 8 2.0219 0.2376 0.1158 0.122 0.353 0.0050 AT 1.1331
8158_4 8 8 1.8610 0.0767 0.0561 0.021 0.133 0.0315 AT 1.0430
8176_5 8 7 1.8324 0.0481 1.0002 − 0.952 1.048 0.9280 N/A 1.0269
8187_3 8 8 1.8010 0.0167 0.0660 − 0.049 0.083 0.6349 N/A 1.0094
8187_4 8 8 1.9886 0.2043 0.1132 0.091 0.318 0.0095 AT 1.1145
8189_3 8 8 2.0520 0.2677 0.1564 0.111 0.424 0.0122 AT 1.1500
8199_3 8 8 2.4459 0.6616 0.2383 0.423 0.900 0.0010 AT 1.3708
8199_4 8 8 2.4312 0.6469 0.1697 0.477 0.817 0.0001 AT 1.3625
8199_5 8 8 2.5618 0.7775 0.0762 0.701 0.854 1.95E− 07 AT 1.4357
8208_3 8 8 1.8682 0.0839 0.0907 − 0.007 0.175 0.113 N/A 1.0470
8208_4 8 8 2.4574 0.6731 0.3703 0.303 1.043 0.009 AT 1.3772
Population 280 273 2.0702 0.2859 0.0538 0.232 0.340 1.258E− 21 AT 1.1602
Population
(edited)
232 232 2.0979 0.3136 0.0446 0.269 0.358 5.656E− 32 AT 1.1757
Male 152 149 2.1657 0.3814 0.0756 0.306 0.457 5.07E− 18 AT 1.2137
Male (edited) 128 128 2.1492 0.3649 0.0650 0.300 0.430 3.409E− 20 AT 1.2045
Female 128 124 1.9555 0.1712 0.0711 0.100 0.242 6.353E− 06 AT 1.0960
Female (edited) 104 104 2.0348 0.2504 0.0571 0.193 0.307 9.278E−14 AT 1.1404
Abbreviations: CI, conﬁdence interval; edited, only cDNA data from samples with no cDNA outliers used; gDNA, genomic DNA; mean gDNA AT:G ratio for
population used= 1.78431493189407; mean gDNA G:AT ratio for population used= 0.567229238822408; n, number of replicate results excluding outliers based
on lying outside 1.5x interquartile range; N, number of replicate results; N/A, not applicable; Sig., signiﬁcance. Signiﬁcance based on paired-samples t-test.
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increase of ﬁbroblast growth factor 8.17 The family of ﬁbroblast
growth factors regulates a plethora of developmental processes,
including brain patterning, branching morphogenesis and limb
development. The recent discovery of the crucial roles of the
endocrine-acting ﬁbroblast growth factor 19 subfamily in bile acid,
glucose and phosphate homeostasis has sparked renewed interest
in the pharmacological potential of this family.18
In this report, we ﬁrst systematically sequenced the 15 exons of
SETDB2 and identiﬁed an AT/G mutation in the 5′-UTR
(rs386770867). The AT allele of this mutation was most highly
associated with IgE levels. EMSA analysis of rs386770867 revealed
three main bandshifts, an AT allele-speciﬁc complex (band 3), a
G-allele-speciﬁc complex (band 2) and a complex present for both
alleles (band 1). The AT-speciﬁc and constant complexes were
seen in all three nuclear extracts used (Calu-3, BEAS-2B and Daudi),
whereas the G-allele-speciﬁc band was only seen in the presence
of the Daudi nuclear extract. Supershift experiments indicated that
the AT allele complex was due to the YY1 transcription factor
binding the probe, whereas the G allele was due to SRY binding.
The differences in binding patterns between cell lines may
therefore indicate varying regulation of SETDB2 in different
tissue types.
YY1 is a transcription factor, so called because of its ability to act
both as an initiator, activator and repressor of transcription.19,20 It
is also known as a member of the GLI-Krüppel family of zinc-ﬁnger
transcription factors.19 The protein is highly conserved and
ubiquitously expressed. Examples of its role as a repressor are
the P5 promoter of adeno-associated virus, c-fos and interleukin-
5.21–23 It is believed that YY1 is a repressor by default, but under
certain conditions its function can be altered to that of an
activator.24
An association between YY1 and asthma has already been
previously reported. Tumor growth factor-β is an asthma
candidate gene, the product of which inhibits B and T cells,
decreases IgE production and mast cell proliferation and induces
eosinophil apoptosis. Subsequently, it has been shown to be
associated with asthma. YY1 has also been shown to inhibit tumor
growth factor-β-induced cell differentiation.25
Sry is the gene required for testis determination and
differentiation in mammals.26 Recent work has also indicated
additional roles for Sry, for instance, in the regulation of tyrosine
hydroxylase gene transcription.27 SRY is sex-speciﬁc and so the
possibility remains that this could be related to the sex-speciﬁc
inﬂuence on asthma, which has previously been reported. For
instance, Weiss et al.28 reported signiﬁcant sex-speciﬁc differences
in FEV1 (forced expiratory volume in 1 s), eosinophils and IgE
levels, all of which are quantitative traits that are associated with
asthma. In addition, two traits, FEV1/FVC (forced vital capacity) and
eosinophil levels, were found to have sex-speciﬁc linkage to
regions of the genome and had signiﬁcant genotype–sex
interactions.28 Interestingly, our allelotyping data did indicate a
stronger preferential expression of the AT allele in males
compared with females. This perhaps indicates a greater
suppression of allele G expression because of SRY binding
in males.
The results of the EMSAs indicate that rs386770867 changes the
sequence from a YY1 binding site to that of SRY. Both transcription
factors are able to activate or repress transcription based on the
circumstances in which binding takes place. Alleotyping revealed
that the AT allele had a modest, but highly signiﬁcant, increased
expression in heterozygous individuals relative to the G allele.
Although the scale of the difference was subtle, this could be of
biological signiﬁcance in conditions enhancing IgE production
in vivo. The dual-luciferase reporter assay showed that the AT
allele signiﬁcantly increases the transcription of luciferase. This
therefore indicates that changing from YY1 to SRY binding as a
result of the rs386770867 variant decreases expression of SETDB2,
consistent with our ﬁndings in relation to allele expression in
males and females.
Although this work provides additional clarity regarding the
mechanisms underlying the chromosome 13q14 asthma locus,
many unanswered questions remain. Recent investigation on
PHF11 found that it not only regulates the T-cell function29,30 but
also is involved in immunoglobulin class switching on B cells.31
Therefore, our ﬁndings support the role of both genes at this locus
inﬂuencing asthma-associated traits, although their relative
inﬂuences are as yet unknown. Future work will need to focus
on the functions of PHF11 and SETDB2 in asthma pathophysiol-
ogy, in particular, how the two molecules work together during
immune cell regulation. Additionally, using expression quantita-
tive trait loci data will help to determine both the functional
effects of rs386770867 and the functional role of SETDB2. The
dissection of regulating elements in the locus will also increase our
understanding of the factors that inﬂuence the expression of
these genes.
MATERIALS AND METHODS
SETDB2 exon sequencing and genotyping of rs386770867
Sanger sequencing of 10 diploid genomes (ﬁve unrelated individuals with
atopic disease and ﬁve unrelated control individuals) together with a pool
of DNA from 32 unrelated individuals for all 15 exons of SETDB2 was
performed. This gave us 99.9% probability of detecting alleles with a
minimum frequency of 0.2 and 99% probability of detecting alleles with a
minimum frequency of 0.1. Dilution experiments with known alleles
indicated that we were able to detect allele frequencies 40.15 with the
pool. An AT/G mutation in the 5′-UTR was identiﬁed, subsequently this
mutation was designated as rs386770867. The mutation was genotyped by
a PCR-based restriction fragment length polymorphism method (forward
primer: 5′-CGACAGTTCCTCTAGCCG-3′; reverse primer: 5′-CTGAGACAGACA
GGCTGTA-3′—generating a PCR product of 167/168 bp). The reverse
primer contained a modiﬁed A to T change (bold) to generate a restriction
enzyme site (5′-GTAC-3′) for Rsal, allowing discrimination between the AT
and G alleles on a 2.5% agarose gel. The mutation was genotyped in
family-based asthma cohorts, which have been described in detail
previously.1 Brieﬂy, the Australian panel consisted of 364 subjects in 80
nuclear families of European descent from the rural town of Busselton in
Western Australia. The families contained a total of 203 offspring forming
172 sib-pairs. The mean age of the children was 12.6 ± 1.3 (s.e.) years, their
geometric mean IgE was 55.7 ± 1.1 k Ul− 1 and their mean skin test index
was 4.0 ± 0.41mm.14 The UK panel consisted of 87 nuclear families of
British descent recruited when a child of the family attended an asthma
clinic in the Oxford region. The families contained 216 offspring (148
sibling pairs) and consisted of 4 large pedigrees and 66 nuclear families.
For analysis, three-generation pedigrees were divided into independent
two-generation pedigrees, to give a total of 88 nuclear families. The father
P < 0.05
P < 0.05
Figure 3. Dual-luciferase reporter assay results of AT and G alleles.
The Renilla pRL-SV40 plasmid was used as a control for the
transfection efﬁciency. The luciferase expression was documented
as average relative light units/pGL3 control.
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was atopic in 31 parent pairs, the mother in 17, both parents in 21 and
neither parent in 5.32 Ethical approvals were given by Australia or the
United Kingdom Multicentre Research Ethics Committee. All subjects or
their parents gave written informed consent to the study. The genotypes
were checked by two experienced researchers. The quantitative trait loci
were analysed by the QTL program as described previously.2
Transcription factor binding search programs
Putative transcription factor binding sites in the sequence spanning
rs386770867 were identiﬁed using the programs TFSEARCH,9 TFSCAN10 and
MatInspector (Genomatix Software GmbH, Munich, Germany).11 Programs
were run using the default settings.
Cell culture and nuclear protein extraction
Daudi (male B lymphoblast), Calu-3 (airway epithelial), BEAS-2B (bronchial
epithelial) and Jurkat (T lymphoblast) cell lines were obtained from the
American Type Culture Collection (Teddington, UK). Airway epithelium and
B and T lymphoblasts are of importance in asthma pathogenesis, making
these cell lines relevant for EMSA investigations. In addition, a SETDB2–
PHF11 gene complex has been shown to be expressed in lung tissue and
lymphocytes.2 Jurkat and Daudi cells were cultured in RPMI 1640 media
(Sigma, Gillingham, UK) supplemented to contain ﬁnal concentrations of
10% fetal bovine serum (Sigma), 10mmol l− 1 HEPES (Sigma), 1 mmol l− 1
sodium pyruvate (Sigma), 4.5 g l− 1 glucose (Sigma), 2 mmol l− 1
L-glutamine (Sigma), 20 Uml− 1 penicillin and 0.1 mgml− 1 streptomycin
(Sigma). Calu-3 cells were cultured in Dulbecco's modiﬁed Eagle's medium
(Sigma), supplemented to contain ﬁnal concentrations of 10% fetal bovine
serum, 1mmol l− 1 sodium pyruvate, 2 mmol l− 1 L-glutamine, 20 Uml− 1
penicillin and 0.1 mgml− 1 streptomycin. BEAS-2B cells were cultured in
keratinocyte-SFM (serum-free medium) (Gibco-BRL, Paisley, UK) media
supplemented with 2mmol l− 1 L-glutamine, 5 ngml− 1 epidermal growth
factor (Gibco-BRL), 50 mgml− 1 bovine pituitary extract (Gibco-BRL),
20 Uml− 1 penicillin and 0.1 mgml− 1 streptomycin. All cell lines were
cultured at 37 °C and 5% CO2. Nuclear extracts were prepared by using a
modiﬁed Schreiber protocol33 and quantiﬁed using the Bradford assay.34
Electrophoretic mobility shift assays
Sense and antisense single-stranded oligonucleotides for both alleles of
rs386770867 were designed and synthesized. Each consisted of the SNP
allele and 15 bases of 5′ and 3′ ﬂanking sequence. An AGCT tag was added
to the 5′ end of each oligonucleotide to facilitate subsequent radiolabel-
ling (rs386770867 in bold): AT allele: forward, GACTGAGTTTCCAACCTCC
ATTTCAGCCTGTCTGTC; reverse, GACTGACAGACAGGCTGAAATGGAGGTTG
GAAACTC; G allele: forward, GACTGAGTTTCCAACCTCCGTTCAGCCTGTCT
GTC; reverse, GACTGACAGACAGGCTGAACGGAGGTTGGAAACTC.
The oligonucleotides were annealed to form probes for both alleles and
labelled with [α-32P]CTP (Amersham Biosciences, Little Chalfont, UK) using
the Klenow fragment (New England Biolabs, Hitchin, UK).35 Typically, EMSA
binding reactions contained 3–5 μg of nuclear extract, 2 μl radiolabelled
probe (40 counts per second per μl), 1 × binding buffer (Promega,
Hampshire, UK), 0.05–0.1 mgml− 1 poly(dIdC)·poly(dI−dC) (Sigma) and 4%
glycerol (Sigma) in a total reaction volume of 15 μl. For competition assays,
reactions included unlabelled competitor probe at a concentration of 10x,
50x or 100x that of the labelled probe. For supershift assays, 2 μg
antibodies were added to the reactions before the ﬁrst incubation step.
The antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA) used for
supershift assays were YY1, SRY and c-Myb. Reactions were incubated
without the labelled probe for 10min at room temperature. On addition of
the labelled probe, reactions were incubated for a further 20min at room
temperature. Products were run on a 6% non-denaturing polyacrylamide
gel at 4 °C and 100 V for ~ 2 h using 0.5x TBE (Tris-borate-EDTA) run buffer
before visualization by exposure to Kodak X-Omat AR ﬁlm (Sigma).
Allelotyping subjects
Allele-speciﬁc expression analysis was performed in a subset of the MRC-A
population, MRC-A/RNA. The MRC-A panel consists of 195 siblings and
their parents in 95 nuclear pedigrees in which we have previously carried
out genome-wide association studies for global gene expression and
asthma status.36,37 Our sample contained 357 subjects (183 male) with a
mean age in children of 12.2 years (ranging from 2 to 39) and adults of 42
years (ranging from 27 to 61 years). One hundred and thirteen children
had doctor diagnosed asthma. Epstein–Barr virus-immortalized
lymphoblastoid cell lines were created from blood taken from all the
children in the population. The MRC-A/RNA cohort is a subset of the MRC-A
population. It is made up of 94 children from the 49 sibling pairs selected
from the 200 families on the basis of being the most highly discordant for
IgE levels. The Epstein–Barr virus cell lines provided a source of both DNA
and RNA from these individuals. Ethical approval was given by the United
Kingdom Multicentre Research Ethics Committee. All subjects or their
parents gave written informed consent to the study.
Allelotyping
Allele-speciﬁc expression analysis was performed using DNA and RNA from
a subset of the MRC-A panel, MRC-A/RNA. Details of the allelotyping
method have been described previously.36 Brieﬂy, 10 μg of RNA was used
to synthesize double-stranded cDNA using the One-cycle cDNA Synthesis
Kit (Affymetrix, Santa Clara, CA, USA). Allele peak areas in the Sequenom
hME Assay (Sequenom, San Diego, CA, USA) mass spectra are directly
proportional to the amount of starting material in the assay. Consequently,
the peak areas provide a method of comparing the relative amounts of
two alleles for a heterozygote. To determine whether allele-speciﬁc
expression is occurring, the ratio of the peak areas in the genomic DNA is
compared with that in the cDNA to account for any natural bias in peak
areas. If the two ratios differ signiﬁcantly, preferential allele expression is
indicated. Ampliﬁcation was performed in 5 μl reaction volumes with
either 5 ng template genomic DNA or cDNA equivalent to 5 ng total RNA.
The PCR program was as detailed previously.38 Replicate PCRs (N=8) for
both genomic DNA and cDNA were performed for each subject. PCR
products were prepared for mass spectrometry following the standard
Sequenom method.39
Statistical analyses of the allele ratios for allelotyping were performed
using Excel 2010 (Microsoft). For paired-samples t-test, unless otherwise
stated, the ratio of the peak areas from the mass spectrometry results of
allele AT relative to allele G in the cDNA was calculated and compared with
the mean ratio in the genomic DNA for all samples to minimize the effect
of any potential variation in genomic DNA ratio.
Dual-luciferase reporter assay
Using the pLG3 promoter plasmid, a construct was made incorporating a
281/280 bp fragment containing rs386770867. PCR primers used were:
forward, ATAAGCTAGCGAGCCAGGTGAAACCAAGGC; reverse, GCTCGCTCG
AGCTTTGACAACCTCAGGTTCC (GCTAGC, Nhel site; CTCGAG, Xhol site). PCRs
were carried out in individuals homozygous for either the AT or G allele.
PCR products were then digested with Nhel and Xhol and the bands
obtained puriﬁed and ligated into the pLG3 promoter plasmid. Clones
were picked, cultured overnight for DNA extraction and then sequenced to
identify the appropriate constructs.
Jurkat T cells were seeded into 12-well plates at 1x106 cells per ml and
1 μg plasmids were transfected with Lonza Amaxa Cell Line NucleofectorT
Kit V (Lonza AG, Castleford, UK). Co-transfection with the Renilla pRL-SV40
plasmid (1 μg per transfect) provided a control for transfection efﬁciency in
a dual-luciferase reporter assay system (Promega). The untransfected pGL3
promoter plasmid was used as the negative control. After 24 h transfection,
a dual-luciferase assay was carried out and expression of luciferase was
measured both according to the manufacturer's protocol. Brieﬂy, the
medium was removed from cultured cells and 100 μl 1x Passive Lysis Buffer
was added to the wells; then, 25 μl Passive Lysis Buffer lysate was
transferred to a new 96-well plate and Luciferase Assay Buffer II was added.
Fireﬂy luciferase activity was measured; then, 100 μl Stop & Glo reagent
(dual-luciferase reporter assay kit, Promega) was added, and Renilla
luciferase activity was measured. Three independent experiments were
performed and results were analysed using the Student’s t-tests.
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